ability to induce a procoagulant state on endothelial cells is a new biological activity of gram-positive cell walls which promotes the participation of the coagulation cascade in the inflammatory response to disease caused by gram-positive organisms.
Early events in the coagulation cascade which contribute to intravascular fibrin formation and deposition include the expression of procoagulant activity (PCA) on surfaces of endothelial cells. Tissue factor is the predominant procoagulant manifested on a variety of cells (10) . Resting endothelial cells possess little or no tissue factor activity. However, perturbation of endothelial cells by different agents, such as endotoxin or tumor necrosis factor, results in induction of PCA and subsequent activation of the entire procoagulant pathway (1, 5, 15) .
Severe pneumococcal infection is commonly complicated by thrombosis and diffuse intravascular coagulation, but the bacterial components inducing PCA in infections caused by gram-positive organisms are unknown. Since cell walls are major determinants of inflammation in infection caused by gram-positive organisms (18, 19) , we studied the ability of intact pneumococci and pneumococcal cell wall components to induce PCA on human umbilical vein endothelial cells (HUVEC) . We show that pneumococcal cell walls efficiently induce PCA on HUVEC, with a specific activity at least as great as that of endotoxin.
(This material was presented in part at the 31st Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, Ill., 29 September to 2 October 1991.) MATERIALS AND METHODS Bacterial components. Streptococcus pneumoniae R6 (unencapsulated) and encapsulated strain S3 (serotype 3) were grown in semisynthetic medium supplemented with 0.5% yeast extract (Difco, Detroit, Mich.) in a stationary water bath at 37°C (19) . At mid-logarithmic phase, the bacteria were centrifuged, washed, and resuspended to a concentration of 108 CFU/ml in phosphate-buffered saline (Whittaker Bioproducts, Walkersville, Md.). Subsequently, the bacteria were killed by being boiled in a water bath for 10 min.
Purified cell wall components from strain R6 were prepared as described previously (17) . Briefly, logarithmically * Corresponding author.
growing pneumococci were heat killed. Crude cell wall was extracted in 5% sodium dodecyl sulfate (SDS) at 100°C for 30 min. After being washed to remove detergent, the cell wall preparation was treated with DNase, RNase, and trypsin. After reprecipitation in SDS, the cell walls were lyophilized and stored at room temperature. Ethanolamine-containing cell wall was prepared in the manner described above with the exception of the growth of pneumococci in defined medium with ethanolamine substituting for choline (17) . Further preparations of cell wall included solubilization with N-acetylmuramyl-L-alanine amidase or Ml muramidase. Lipoteichoic acid (Forssman antigen) was prepared by the extraction procedure adapted from the method of Goebel as described previously (17) followed by purification over an antiphosphorylcholine antibody column (17 Preliminary experiments showed that PCA induction by intact pneumococci, pneumococcal cell wall components, or LPS did not differ when measured on low-passage (passages 2 to 4) or high-passage (passage 12 or 13) endothelial cell lines.
PCA assay. PCA of endothelial cell monolayers was assessed in a one-stage clotting assay as described by Nawroth et al. (9) . The endothelial cell monolayers were washed twice in RPMI 1640 (Whittaker Bioproducts) containing HEPES, L-glutamine, penicillin, and streptomycin as described above. One milliliter of fresh medium and 100 ,ul of test sample containing the indicated concentrations of intact pneumococci, pneumococcal cell surface components, or endotoxin were added to duplicate wells containing 106 endothelial cells. After incubation in a 5% CO2 incubator at 37°C for the indicated times, the samples were washed twice with RPMI buffer. To measure surface PCA, 250 pl of citrated human plasma and 250 pul of 20 mM CaCl2 were added to the endothelial cells at 37°C to initiate the reaction. The time from CaC12 addition to the visual detection of a fibrin gel was recorded. Total intracellular and extracellular PCA was determined by using endothelial cells which were frozen and thawed after exposure to bacteria or cell surface components.
PCA tissue factor-like activity was expressed as shortening of the clotting time (seconds) or as milliunits per 106 endothelial cells in comparison with a rabbit brain thromboplastin standard (Baxter Healthcare Corporation, Miami, Fla.), in which 36 mg (dry weight) was assigned a value of 100,000 mU of PCA. The assay was used over the range of 1 to 10,000 mU of PCA, with this range being linear with normal plasma substrate. Previous studies have shown that PCA induced by bacteria and endotoxin are tissue factor-like activities, making comparison with a thromboplastin standard appropriate (13, 14) . Statistics . Differences between groups were tested by Student's t test. The results are expressed as meansstandard deviations (SD).
RESULTS
Induction of PCA by intact S. pneumoniae. The time course for induction of PCA on endothelial cells after incubation with pneumococci (108 CFU/ml) is shown in Fig. 1 . Total PCA (intracellular and surface PCA) induced by S. pneumoniae was first detectable at 30 min and peaked at 2 h. At this time point, a maximum shortening of the clotting time by 55 ± 7 s compared with the time for the total PCA of nonstimulated endothelial cells was achieved. This clotting time, compared with that of a thromboplastin standard, translated to approximately 550 mU of PCA. PCA decreased rapidly between 2 1/2 and 3 h; no PCA was detected at 6, 18, or 24 h. Surface PCA activity followed a similar but somewhat delayed time course compared with total PCA activity, peaking at 2 h but disappearing more gradually between 3 and 6 h (Fig. 1) .
The effects of various concentrations of intact S. pneumoniae on peak endothelial cell PCA production at 2 h are shown in Fig. 2 cocci per ml was as potent as 25 pug of endotoxin in the PCA assay (Fig. 3) .
PCA induction by unencapsulated versus encapsulated pneumococci. To explore the effect of the presence of the polysaccharide capsule on PCA induction, unencapsulated strain R6 and encapsulated strain S3 were compared in the PCA assay. Coagulation times for endothelial cells incubated with R6 or S3 at a concentration of 108 CFU/ml were shortened to 61.8% ± 8% and 60.7% ± 9% (mean ± SD; P > 0.5), respectively, of the coagulation time of unstimulated cells.
Induction of PCA by pneumococcal cell walls and pneumococcal cell surface components. In order to more specifically 175' define the component of the pneumococcus reinducing PCA, the capacity of pneumococcal c cell surface components to induce PCA was ; walls are large macromolecules which are nec cult to prepare as a homogeneous suspensi sonication, concentrations of the samples m; variability in the outcome of assays using these may be expected.
The amount of PCA induced by pneumococ was dose dependent (Fig. 4) . The coagulation tin by a maximum of 53 + 8 s, which is equivalen mately 550 mU of PCA. Maximum PCA was a a cell wall dose at or above 25 ,ug/ml; higher cc of cell wall did not further decrease the coagi Although a higher concentration of endotoxin ii PCA, the maximum inductions of PCA by pneun (P > 0.5).
The induction of PCA by pneumococcal cell wall components is shown in Table 1 . Native choline-containing purified cell wall (50 p,g/ml) was found to be significantly (P < 0.025) more active than ethanolamine-containing cell wall (50 ,ug/ ml). To determine whether soluble cell wall subcomponents retained the ability to induce PCA, disaccharide peptides (generated by Ml muramidase digestion), peptides dissociated from the glycan backbone by amidase digestion, and lipid-linked teichoic acid (Forssman antigen) were compared at 50 p,g/ml. The disaccharide peptides and lipoteichoic acid retained the ability to induce PCA, while the amidasedigested cell wall lost the ability.
DISCUSSION with
The occurrence of vascular complications (purpura) and ncentrations coagulation disorders in pneumococcal disease has long ulation time.
been recognized (2, 8) . Previous studies have suggested that nduced more a high-molecular-weight complex from the pneumococcal nococcal cell cell wall generates purpura when introduced intraperitoneally into mice (4) . Although the mechanism of such effects is unclear, activation of the coagulation cascade is likely to participate in these phenomena and expression of PCA on cell surfaces would be expected to occur as an early event (13) (14) (15) . In this study, we show that pneumococci and, specifically, pneumococcal cell walls are potent inducers of PCA on human endothelial cells.
Induction of PCA by S. pneumoniae occurred rapidly, -10 peaking at 2 h and disappearing after 6 h. This time course 10 '°< was similar to that of endotoxin (Fig. 3) . Longer incubation times of 4 to 16 h have been associated with induction of PCA on human macrophages by bacteria such as Bacteroi--100 des fragilis, E. coli, and Staphylococcus aureus (13, 14) . This difference may indicate that endothelial cells are more susceptible to perturbation by microorganisms than are _ 1000 macrophages and that tissue factor-like PCA is more rapidly 60 generated on endothelial cells than on macrophages.
The time course of induction of surface PCA lagged behind that of total PCA, suggesting that the PCA was due to (19) . Although the polysaccharide capsule has been recognized as an important virulence factor preventing efficient opsonization, evidence that the pneumococcal components responsible for the generation of the inflammatory response lie underneath the capsule is strong (12, (17) (18) (19) . The capacity of encapsulated strain S3 and unencapsulated strain R6 to induce equivalent PCA suggests that the capsule (at least type III polysaccharide) neither promotes nor inhibits PCA induction by pneumococci. Since type III disease is one of the most virulent, this lack of effect may be shared by most capsular types.
Purified pneumococcal cell wall was a potent inducer of PCA. Induction of PCA by cell wall was dose dependent. Maximum induction was achieved with 25 ,ug of cell wall; larger doses did not further shorten the clotting time. PCA inductions by 25 ,ug of pneumococcal cell wall and by 25 jig of endotoxin were similar. Twenty-five micrograms represents the amount of cell wall present in 108 pneumococci, while that amount of endotoxin is found in 1010 gramnegative microorganisms (6) . Thus, it may be possible that for a given bacterial load, the capacity of pneumococci to induce PCA is much stronger than that of gram-negative bacteria.
The amount of PCA induced by 108 pneumococci (550 mU) was equivalent to that induced by 25 ,ug of cell wall (500 mU) derived from the same number of bacteria ( Fig. 2 versus  4 ). This suggests that the cell wall is a major determinant of this bioactivity of pneumococci. Some subcomponents of the pneumococcal cell wall retained the ability to induce PCA, similar to intact cell wall. The teichoic acid, particularly the phosphorylcholine moiety, appeared to be an important determinant of the ability of cell wall to induce PCA. Substitution of the native choline in the wall with ethanolamine greatly reduced PCA induction, a finding consistent with the loss of activity of ethanolamine-containing cell wall in assays of induction of interleukin-1 and plateletactivating factor in vitro (3, 11) . Ml muramidase-digested cell wall, but not amidase-digested cell wall, was still capable of inducing PCA. This suggests that while soluble cell wall particles generated by enzymatic digestion of the cell wall can induce PCA, the linkage of the peptide side chains to the carbohydrate backbone may be necessary for this activity. Antibiotic-induced lysis of pneumococci results in degradation of the cell wall by the amidase. The inability of amidasegenerated fragments to induce PCA suggests that bacterial killing may not be associated with enhanced induction of PCA.
The mechanism by which pneumococci and pneumococcal cell wall components induce PCA is not yet understood. Pneumococci avidly adhere to HUVEC (Sa), and cell walls bound to leukocytes, endothelia, and epithelia have been visualized in vivo (16, 17) . Cell walls induce interleukin-1 production from leukocytes (11) . Thus, it may be possible that the cell wall induces tissue factor expression on the endothelial cells by stimulating interleukin-1 synthesis, as has been postulated for other agents (7) . Pneumococcal cell walls have been shown to induce the spectrum of inflammatory responses characteristic of pneumococcal infection of the subarachnoid space (15) , lung (17) , and ear (12) . The induction of PCA indicates that the ability to trigger the coagulation cascade can be added to the known biological effects of cell wall for activation of the complement, cytokine, platelet-activating factor, and arachidonate cascades.
